Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new treatment options.

More than 70 children, on average, are diagnosed with cancer each year at CHKD. Anthem LemonAid is a fundraising campaign ...

Stage 3 lymphoma is a lymphatic cancer that has spread to lymph nodes above and below the diaphragm. Learn its symptoms, ...

Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell ...

Along with PET, ctDNA offers novel benefits in identifying genetic subgroups and guiding treatment adjustments to assess acalabrutinib’s role in non-chemotherapy responders.

Novel lymphoma microenvironment profiles presage response to CAR T-cell therapy in large B-cell lymphoma.

In July 2020, Monjuvi in combination with lenalidomide received FDA approval for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

Treatment for non-Hodgkin lymphoma can depend on the type and stage. Learn more here.

New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...